Recon: Becerra signals more time needed to nominate FDA chief; CureVac vaccine disappoints in pivotal trial
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsDiagnostics/IVDsMedical DevicesPharmaceuticals